| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/03/2013 | WO2013001524A1 Method for removing a lytic enzyme from a heterogeneous mixture |
| 01/03/2013 | WO2013001517A1 Polypeptides and uses thereof for treatment of autoimmune disorders and infection |
| 01/03/2013 | WO2013001435A1 Phacosporacea resistant soybean plants |
| 01/03/2013 | WO2013001297A1 Binding inhibitors of the beta.transducin repeat - containing protein |
| 01/03/2013 | WO2013001285A2 Peptide |
| 01/03/2013 | WO2013001130A1 Lrp1 as key receptor for the transfer of sterified cholesterol from very-low-density lipoproteins (vldl) to ischaemic cardiac muscle |
| 01/03/2013 | WO2013001103A1 Method for obtaining collagen from animal skin |
| 01/03/2013 | WO2013001087A2 Method for screening alpha-amylases |
| 01/03/2013 | WO2013001041A1 Peptides with viral infection enhancing properties and their use |
| 01/03/2013 | WO2013000980A1 Recombinant mistletoe lectin and use thereof as an adjuvant |
| 01/03/2013 | WO2013000905A1 Canine coronavirus vaccine |
| 01/03/2013 | WO2013000064A1 Alternative splicing modulators and splice variants and their use in the control and detection of pluripotency and differentiation |
| 01/03/2013 | WO2012148720A3 Anti-microbial peptides and methods of use thereof |
| 01/03/2013 | WO2012145680A3 Anti-microbial peptides and uses therefore |
| 01/03/2013 | WO2012145523A3 Aav mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity |
| 01/03/2013 | WO2012141504A3 Brg-1-derived bromodomain, and use thereof |
| 01/03/2013 | WO2012125973A3 Potent and selective inhibitors of nav1.3 and nav1.7 |
| 01/03/2013 | WO2012117336A3 Apoptosis-inducing molecules and uses therefor |
| 01/03/2013 | WO2012093258A3 Irf5- related treatment and screening |
| 01/03/2013 | US20130007920 Stomata-increasing agent, polypeptide, method for increasing number and/or density of stomata in plant, and method for increasing yield of plant |
| 01/03/2013 | US20130007918 Sunn hemp cultivars capable of producing seed within the continental united states |
| 01/03/2013 | US20130005951 Process for preparing fgf21 with low degree of o-glycosylation |
| 01/03/2013 | US20130005947 Method for removing a lytic enzyme from a heterogeneous mixture |
| 01/03/2013 | US20130005946 Canola protein product with low phytic acid content ("c702") |
| 01/03/2013 | US20130005944 CXCR4 Receptor Compounds |
| 01/03/2013 | US20130005668 Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer |
| 01/03/2013 | US20130005667 Heterologous expression of neisserial proteins |
| 01/03/2013 | US20130005661 Pharmaceutical compositions |
| 01/03/2013 | US20130005660 Plasma Activation of Biological Materials for Surface Modification |
| 01/03/2013 | US20130005659 Il-17 binding compounds and medical uses thereof |
| 01/03/2013 | US20130005651 Death associated protein 1 variants and use thereof for modulating autophagy |
| 01/03/2013 | US20130005647 Mutant nisin ser 29 derivatives and the use thereof |
| 01/03/2013 | US20130005646 Polypeptides |
| 01/03/2013 | US20130005645 Apoe peptide dimers and uses thereof |
| 01/03/2013 | US20130005644 Cyclic agonists and antagonists of c5a receptors and g protein-coupled receptors |
| 01/03/2013 | US20130005048 Indicator device |
| 01/03/2013 | US20130004991 Positive cytomodulines to improve bioreactor productivity |
| 01/03/2013 | US20130004971 CYSTATIN C, beta2 MICROGLOBULIN, alpha1 MICROGLOBULIN AND GENES FOR SAME, ANTIBODY, AND KIT AND METHOD FOR DIAGNOSIS OF FELINE NEPHROPATHY |
| 01/03/2013 | US20130004961 Methods of detecting a sweet-sensitive cell |
| 01/03/2013 | US20130004955 Ovary Tumor Markers and Methods of Use Thereof |
| 01/03/2013 | US20130004564 Antimicrobial peptides |
| 01/03/2013 | US20130004531 Immunogens from uropathogenic escherichia coli |
| 01/03/2013 | US20130004529 Vaccines and methods for using the same |
| 01/03/2013 | US20130004527 Contiguous overlapping peptides for treatment of ragweed pollen allergy |
| 01/03/2013 | US20130004524 Conjugated Proteins |
| 01/03/2013 | US20130004513 Agents for treating disease |
| 01/03/2013 | US20130004510 Vaccine |
| 01/03/2013 | US20130004487 Scd40l and placental growth factor (pigf) as biochemical marker combinations in cardiovascular diseases |
| 01/03/2013 | US20130004469 Engineered lumenized vascular networks and support matrix |
| 01/03/2013 | US20130004462 Modified factor viii and factor ix genes and vectors for gene therapy |
| 01/03/2013 | US20130004461 Subfamily e simian adenoviruses a1321, a1325, a1295, a1309, a1316 and a1322 and uses thereof |
| 01/03/2013 | US20130004431 Transport agents for crossing the blood-brain barrier and into brain cancer cells and methods of use thereof |
| 01/03/2013 | US20130004421 Radiolabeled affibody molecules |
| 01/03/2013 | CA2840577A1 Soluble integrin .alpha.4 mutant |
| 01/03/2013 | CA2840494A1 Wheat protein isolates and processes for producing |
| 01/03/2013 | CA2840335A1 Recombinant mistletoe lectin and use thereof as an adjuvant |
| 01/03/2013 | CA2839938A1 Photoactivatable receptors and their uses |
| 01/03/2013 | CA2839832A1 Contiguous overlapping peptides for treatment of ragweed pollen allergy |
| 01/03/2013 | CA2839668A1 Epitope and its use of hepatitis b virus surface antigen |
| 01/03/2013 | CA2839663A1 Receptor gene for peptide cancer antigen-specific t cell |
| 01/03/2013 | CA2839633A1 Peptides with viral infection enhancing properties and their use |
| 01/03/2013 | CA2839622A1 Wap domain fusion polypeptides and methods of use thereof |
| 01/03/2013 | CA2839619A1 Serpin fusion polypeptides and methods of use thereof |
| 01/03/2013 | CA2839506A1 Canine coronavirus vaccine |
| 01/03/2013 | CA2839462A1 Inhibitors of t-cell activation |
| 01/03/2013 | CA2838795A1 Phacosporacea resistant soybean plants |
| 01/03/2013 | CA2838290A1 Sulfation of wnt pathway proteins |
| 01/03/2013 | CA2836855A1 Polypeptides and uses thereof for treatment of autoimmune disorders and infection |
| 01/02/2013 | EP2540740A2 Multimeric TNF receptors |
| 01/02/2013 | EP2540739A1 Oligopeptide improving differentiation of osteoblasts |
| 01/02/2013 | EP2540738A1 Method for extracting staphylococcus aureus antigen, reagent for extracting staphylococcus aureus antigen, and method for testing staphylococcus aureus |
| 01/02/2013 | EP2540737A1 Use of multivalent synthetic ligands of surface nucleolin for the treatment of inflammation |
| 01/02/2013 | EP2540312A1 Avian influenza chimeric VLPS |
| 01/02/2013 | EP2539437A2 SMOOTH MUSCLE-LIKE CELLS (SMLCs) DERIVED FROM HUMAN PLURIPOTENT STEM CELLS |
| 01/02/2013 | EP2539433A2 Improved microbial fuel cell |
| 01/02/2013 | EP2539364A1 Peptides for treatment of obesity |
| 01/02/2013 | EP2539363A2 Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof |
| 01/02/2013 | EP2539362A1 Nematode-resistant transgenic plants |
| 01/02/2013 | EP2539361A1 Plants having enhanced yield-related traits and a method for making the same |
| 01/02/2013 | EP2539360A1 Immunogenic proteins and compositions |
| 01/02/2013 | EP2539359A2 Clostridium gene |
| 01/02/2013 | EP2538988A2 Methods for tissue decellularization |
| 01/02/2013 | EP2538972A1 Recombinant cdv compositions and uses thereof |
| 01/02/2013 | EP2538971A1 Combination vaccine for streptococcus |
| 01/02/2013 | EP2538964A1 Modulation of cytokine-induced chronic inflammatory responses |
| 01/02/2013 | EP2538959A1 Compounds for the treatment of inflammation and neutropenia |
| 01/02/2013 | EP2479193A9 Homodimer of insulinotropic peptide analogues and method for preparation thereof and use thereof |
| 01/02/2013 | CN1886148B Selective inhibition of NF-kB activation by peptides designed to disrupt NEMO oligomerization |
| 01/02/2013 | CN1854157B Antibodies to insulin-like growth factor i receptor |
| 01/02/2013 | CN1674934B Vaccine compositions containing amyloid beta1-6 antigen arrays |
| 01/02/2013 | CN1658899B Modified CEA nucleic acid and expression vectors |
| 01/02/2013 | CN1454215B Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/02/2013 | CN102858978A High-purity soluble thrombomodulin and method for producing same |
| 01/02/2013 | CN102858962A Compositions for increasing polypeptide stability and activity, and related methods |
| 01/02/2013 | CN102858960A Plasmids and methods for peptide display and affinity-selection on virus-like particles of rna bacteriophages |
| 01/02/2013 | CN102858959A Oncolytic rhabdovirus |
| 01/02/2013 | CN102858802A Human antigen binding proteins that bind beta-KLOTHO, FGF receptors and complexes thereof |
| 01/02/2013 | CN102858797A Process for the purification of a growth factor protein |
| 01/02/2013 | CN102858796A Oligomer-specific amyloid beta epitope and antibodies |
| 01/02/2013 | CN102858795A Use of proteases for gluten intolerance |